LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

Search

STERIS PLC

Open

SectorHealthcare

247.97 0.18

Overview

Share price change

24h

Current

Min

246.07

Max

248.39

Key metrics

By Trading Economics

Income

32M

178M

Sales

-89M

1.4B

P/E

Sector Avg

37.471

35.733

EPS

2.34

Dividend yield

0.93

Profit margin

12.796

Employees

17,787

EBITDA

30M

367M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+15.61% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.93%

3.13%

Next Dividend date

26 Sept 2025

Next Ex Dividend date

18 Nov 2025

Market Stats

By TradingEconomics

Market Cap

1.7B

24B

Previous open

247.79

Previous close

247.97

News Sentiment

By Acuity

79%

21%

352 / 371 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

STERIS PLC Chart

Past performance is not a reliable indicator of future results.

Related News

6 Aug 2025, 20:30 UTC

Earnings

Steris 1Q Adj EPS $2.34 >STE

6 Aug 2025, 20:30 UTC

Earnings

Steris 1Q Rev $1.4B >STE

14 May 2025, 20:30 UTC

Earnings

Steris Sees FY Adj EPS $9.90-Adj EPS $10.15 >STE

14 May 2025, 20:30 UTC

Earnings

Steris 4Q Rev $1.5B >STE

14 May 2025, 20:30 UTC

Earnings

Steris 4Q Adj EPS $2.74 >STE

5 Feb 2025, 21:35 UTC

Earnings

Steris: Outlook Does Not Reflect Any Potential Impact From New Tariffs >STE

5 Feb 2025, 21:34 UTC

Earnings

Steris: FY25 Guidance Change Is Primarily Due to Currency >STE

5 Feb 2025, 21:34 UTC

Earnings

Steris Cuts FY25 Revenue View to Increase of About 6% From Prior View for 6.5%-7%>STE

5 Feb 2025, 21:33 UTC

Earnings

Steris 3Q EPS $1.75 >STE

5 Feb 2025, 21:30 UTC

Earnings

Steris Sees FY Adj EPS $9.05-Adj EPS $9.15 >STE

5 Feb 2025, 21:30 UTC

Earnings

Steris 3Q Rev $1.4B >STE

5 Feb 2025, 21:30 UTC

Earnings

Steris 3Q Adj EPS $2.32 >STE

6 Nov 2024, 21:41 UTC

Earnings

Steris Backs FY25 Revenue Up 6.5%-7.5% >STE

6 Nov 2024, 21:40 UTC

Earnings

Steris 2Q EPS $1.51 >STE

6 Nov 2024, 21:30 UTC

Earnings

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

6 Nov 2024, 21:30 UTC

Earnings

Steris 2Q Adj EPS $2.14 >STE

6 Nov 2024, 21:30 UTC

Earnings

Steris 2Q Rev $1.3B >STE

Peer Comparison

Price change

STERIS PLC Forecast

Price Target

By TipRanks

15.61% upside

12 Months Forecast

Average 283.6 USD  15.61%

High 295 USD

Low 270 USD

Based on 6 Wall Street analysts offering 12 month price targets forSTERIS PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

5

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

225 / 226.35Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Strong Bullish Evidence

Sentiment

By Acuity

352 / 371 Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
help-icon Live chat